![](https://www.diabetesnews.com/wp-content/uploads/2012/04/pill-bottle-Charles-Williams-text-150x150.jpg)
Imeglimin is a new, first-in-class blood-glucose-lowering drug. It is currently in phase 3 trials and has so far proven to be safe and efficient whether used alone or in combination with other drugs to lower A1C in patients with type 2 diabetes. Read more